Enanta Pharmaceuticals
ENTA
#8088
Rank
โ‚ฌ0.33 B
Marketcap
11,37ย โ‚ฌ
Share price
-2.08%
Change (1 day)
72.02%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚ฌ43.92 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ69.21 Million. In 2025 the company made an earning of -โ‚ฌ55.27 Million, an increase over its 2024 earnings that were of -โ‚ฌ83.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ43.92 Million-20.53%
2025 -โ‚ฌ55.27 Million-34.07%
2024 -โ‚ฌ83.83 Million-23.87%
2023 -โ‚ฌ0.12 Billion4.39%
2022 -โ‚ฌ0.11 Billion-4.4%
2021 -โ‚ฌ0.12 Billion91.12%
2020 -โ‚ฌ57.73 Million-407.13%
2019 โ‚ฌ18.79 M-78.63%
2018 โ‚ฌ87.97 M117.97%
2017 โ‚ฌ40.35 M-574.65%
2016 -โ‚ฌ8.51 Million-110.83%
2015 โ‚ฌ78.53 M-4.5%
2014 โ‚ฌ82.23 M-638.53%
2013 -โ‚ฌ15.27 Million-137.98%
2012 โ‚ฌ40.19 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.44 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.63 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚ฌ5.16 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.37 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.36 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ8.29 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA